Clinical Trial Update: Cardioprotection in AML [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study on cardioprotection in acute myeloid leukemia that is currently recruiting. The sponsor listed is the Unive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University of Virginia | Conditions: AML, Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING